Filipe Neves

Title: Innovations by Inventor Filipe Neves in Pharmaceutical Formulations

Introduction

Filipe Neves, an accomplished inventor based in Lisbon, Portugal, has made significant contributions to the field of pharmaceutical sciences. With a portfolio that includes three patents, Neves has focused on innovative methods of producing inhalable particles for medical applications. His expertise lies in developing formulations that enhance the effectiveness of drug delivery for respiratory diseases.

Latest Patents

Filipe Neves' latest patents showcase his pioneering work in the pharmaceutical sector. One notable patent is the "Method of production of inhalable composite particles using a three-fluid nozzle." This innovative method outlines a process for creating a pharmaceutical formulation suitable for inhalation. It involves providing a solution with a poorly water-soluble active agent, followed by a second solution containing an excipient. Both solutions are dried simultaneously in a spray dryer equipped with a three-fluid nozzle, resulting in particles that amalgamate the active agent and the excipient.

Another significant patent is the "Preparation of respirable zafirlukast particles." This patent details a method for preparing respirable zafirlukast monohydrate particles, beginning with the formation of an aqueous suspension of amorphous zafirlukast. It further includes size-reduction to create crystalline monohydrate nanoparticles, leading to the isolation of dry powder. The resultant zafirlukast respirable particles are characterized by their crystalline structure, making them suitable for treating respiratory diseases.

Career Highlights

Throughout his career, Filipe Neves has worked with prominent companies, such as Hovione Scientia Limited and Cipla Limited. His roles in these organizations have allowed him to develop and refine his innovative approaches in pharmaceutical formulation and drug delivery.

Collaborations

Filipe Neves has collaborated with talented professionals, including Eunice Costa and Claudia Moura. Their collective efforts have furthered research and development in the realm of inhalable pharmaceuticals, enhancing the impact of their innovations.

Conclusion

Filipe Neves represents a significant figure in the pharmaceutical innovation landscape. His groundbreaking patents and collaborative spirit continue to contribute to advancements in medication delivery systems. As respiratory diseases remain a major health concern, Neves' work holds the promise of improving treatment methods and patient outcomes in the near future.